Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.42 |
| ▸ | CA2 | P00918 | 6/20 | 0.42 |
| ▸ | CA9 | Q16790 | 5/20 | 0.42 |
| ▸ | CA12 | O43570 | 5/20 | 0.42 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.42 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4630027 | 0.94 | CA9 (0.46) | CA1CA2CA9CA12MAPT | |
| SCHEMBL4631325 | 0.90 | KDM4E (0.41) | CA1CA2CA9CA12DNASE1L3 | |
| SCHEMBL14008329 | 0.86 | KDM4E (0.50) | MAPTKDM4EALDH1A1HPGDGAA | |
| SCHEMBL4631742 | 0.85 | MAPT (0.42) | CA1CA2CA9CA12DNASE1L3 | |
| SCHEMBL4630010 | 0.84 | CA9 (0.42) | CA1CA2CA9CA12MAPT | |
| SCHEMBL14008331 | 0.81 | KDM4E (0.48) | MAPTKDM4EALDH1A1HPGDGAA | |
| SCHEMBL4630755 | 0.79 | MAPT (0.42) | CA1CA2CA9CA12MAPT | |
| SCHEMBL14008335 | 0.79 | KDM4E (0.51) | MAPTKDM4EALDH1A1HPGDGAA | |
| SCHEMBL28520428 | 0.78 | ABCB1 (0.48) | MAPTKDM4EALDH1A1HPGDGAA | |
| SCHEMBL4630565 | 0.77 | USP2 (0.47) | MAPTKDM4EALDH1A1HPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080275215-A1 | Fluorescein-Based Compounds And Their Use For Peptide Synthesis | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-11-06 | — | — | US | disclosed |
| EP-1749870-B1 | Fluorescein-based compounds and their use for peptide synthesis | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007029122-A2 | FLUORESCEIN-BASED COMPOUNDS AND THEIR USE FOR PEPTIDE SYNTHESIS | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2007-03-15 | — | — | WO | disclosed |
| EP-1749870-A1 | Fluorescein-based compounds and their use for peptide synthesis | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2007-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275215-A1 | Fluorescein-Based Compounds And Their Use For Peptide Synthesis | DNPEP, ANPEP, PEPD | CA1 1158/4885CA2 2196/4885CA9 1617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.